A. Veerman

Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment

Amy de Haar-Holleman, Meyling Cheok, Monique L. den Boer et al. · New England Journal of Medicine · 2004 · 643 citations · Full text

In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

Gertjan J.L. Kaspers, A. Veerman, Rob Pieters et al. · Blood · 1997 · 270 citations · Full text

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL

Roland P. Kuiper, Esmé Waanders, Vincent H. J. van der Velden et al. · Leukemia · 2010 · 269 citations

Ikzf1 Deletions, Hematological Malignancy, Pediatric Hematology +7

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)

A. Veerman, Willem A. Kamps, Henk van den Berg et al. · The Lancet Oncology · 2009 · 247 citations

Hematological Malignancy, Protocol All-9, Lymphoid Neoplasia +8

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants

R. Pieters, Monique L. den Boer, M. Durian et al. · Leukemia · 1998 · 242 citations · Full text

Hematological Malignancy, Vitro Drug Resistance, Pediatric Epidemiology +7